Skip to content

Clinical trials

Completed Phase 1/2 Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 1/2 Status: Completed Clear all

144 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20012
20027
200313
20045
200510
20067
20077
20089
20097
20103
20113
20129
20135
20149
20154
20165
20174
20182
20193
20215
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed144

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center11
Memorial Sloan Kettering Cancer Center8
National Cancer Institute (NCI)7
Fred Hutchinson Cancer Center5
Northwestern University4
BioCryst Pharmaceuticals3
Hoffmann-La Roche3
Incyte Corporation3
Masonic Cancer Center, University of Minnesota3
Pharmacyclics LLC.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma144
Lymphoma, Non-Hodgkin47
Leukemia46
Lymphoma, Follicular40
Lymphoma, Large B-Cell, Diffuse39
Leukemia, Lymphocytic, Chronic, B-Cell38
Hodgkin Disease37
Lymphoma, Mantle-Cell37
Lymphoma, B-Cell, Marginal Zone28
Precursor Cell Lymphoblastic Leukemia-Lymphoma28

Trials

Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.

44 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.